Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinomaHyo Song Kim, Byoung Chul Cho, Da Hyun Jung et al.|Oncotarget|2014Cited by 34
SOX5 inhibition overcomes PARP inhibitor resistance in BRCA-mutated breast and ovarian cancerMithun Ghosh, Yong Wha Moon|Cell Death and Disease|2025Cited by 4
Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.Hyo Song Kim, Byoung Chul Cho, Seung Eun Lee et al.|PubMed Central|2015Cited by 1
JPI-547, a novel dual inhibitor of PARP1/2 and tankyrase is more effective than first-generation PARP inhibitors in preclinical BRCA1/2-mutated cancer modelsMin Sil Kang, Yong Wha Moon|British Journal of Cancer|2026Cited by 0